about
Lipid Nanoparticles for Ocular Gene DeliveryEye irritation testing of nanomaterials using the EpiOcular™ eye irritation test and the bovine corneal opacity and permeability assayNanoparticle-based technologies for retinal gene therapyIndomethacin-loaded solid lipid nanoparticles for ocular delivery: development, characterization, and in vitro evaluation.Chitosan-Based Multifunctional Platforms for Local Delivery of Therapeutics.Physicochemical characterization techniques for solid lipid nanoparticles: principles and limitations.Biological voyage of solid lipid nanoparticles: a proficient carrier in nanomedicine.Neuroprotective therapies in glaucoma: I. Neurotrophic factor delivery.Ocular delivery systems for topical application of anti-infective agents.Exploitation of lipid-polymeric matrices at nanoscale for drug delivery applications.Nanocrystal for ocular drug delivery: hope or hype.Application of lipid nanoparticles to ocular drug delivery.Development of microemulsions for ocular delivery.Nanoparticles for drug delivery to the anterior segment of the eye.Fabrication and evaluation of lipid nanoparticulates for ocular delivery of a COX-2 inhibitor.Novel lutein loaded lipid nanoparticles on porcine corneal distribution.A comparative histological study on the skin occlusion performance of a cream made of solid lipid nanoparticles and Vaseline.Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir.Comet assay reveals no genotoxicity risk of cationic solid lipid nanoparticles.Ocular delivery of proteins and peptides: challenges and novel formulation approaches.Sialic acid-modified solid lipid nanoparticles as vascular endothelium-targeting carriers for ischemia-reperfusion-induced acute renal injury.Recent advances in topical nano drug-delivery systems for the anterior ocular segment.[Nanoparticles as drug delivery systems in ophthalmology].Ocular Drug Delivery Barriers-Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases.Advances in nanotechnology-based carrier systems for targeted delivery of bioactive drug molecules with special emphasis on immunotherapy in drug resistant tuberculosis - a critical review.ThiomersNanotechnology as Emerging Tool for Enhancing Solubility of Poorly Water-Soluble Drugs
P2860
Q26823895-4AE07408-51E3-4D1F-8FF9-CD331550C485Q28392387-D967AC99-A875-43AA-884F-DA40782D0FF6Q35843512-4BA5C156-AA30-4C78-BF47-D4F050DE620DQ36697414-547BBD8E-6AD9-4C2C-83D8-F41DAB8C7DC7Q37721800-9DF5086C-781E-4BC7-9624-E7E4D4D51717Q38207151-0BCA08C7-D23E-40B0-BACB-2C56356CFFB3Q38558905-EF91A950-B705-4AB0-B7D2-7D770443A4D0Q38573732-85E350AF-9C6E-4A1B-8C1D-DFB0E9CB1DE6Q38577846-7504A28B-B038-4B42-A588-A7C8EA28D701Q38816436-685B9EE1-CC74-4738-BB31-7441DE5A7789Q38831205-30C410B8-CE29-41CE-BE5E-A4E531335273Q38862505-53B11D56-4D50-40E9-AC3E-734B0D0C5B5BQ39210541-34126E1A-4394-482F-BD3C-C20FC8663DECQ39230212-2A1F6CCD-1E24-4B6C-9698-22DE88E29B13Q39810160-E347A630-E43F-40BC-B202-DB96359DC7AFQ42738490-2DDFF749-DCA7-48C8-85B5-6A39831FF7FDQ43115608-61879678-2740-4A82-9B99-4387BC7F8A46Q43811991-A7578CB7-1FA1-499D-9B92-D73B0EFFFEBCQ45787137-4736674E-B21A-43D0-A9B0-A8E40DC83826Q47729137-F955846B-2E61-4466-882A-70AD236C171EQ49499818-38885DB6-CA5B-4F80-B7ED-A912AF3925E5Q50082031-45FB1B75-FFCA-43F7-97D5-F99A0E886B28Q50129671-F7CC9D39-A2CD-454A-9EDF-D7128183ED75Q52679059-EACFF7B3-6082-4539-876A-F23BA75AAEADQ53379436-3BB0A18A-9866-46DF-AE42-DCE15C102068Q57340488-5A012CAA-D8D4-40C2-83A2-030346BC250DQ57343790-0CF8D710-D102-410F-A264-B1CEEEA538CA
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Solid lipid nanoparticles for ocular drug delivery.
@ast
Solid lipid nanoparticles for ocular drug delivery.
@en
Solid lipid nanoparticles for ocular drug delivery.
@nl
type
label
Solid lipid nanoparticles for ocular drug delivery.
@ast
Solid lipid nanoparticles for ocular drug delivery.
@en
Solid lipid nanoparticles for ocular drug delivery.
@nl
prefLabel
Solid lipid nanoparticles for ocular drug delivery.
@ast
Solid lipid nanoparticles for ocular drug delivery.
@en
Solid lipid nanoparticles for ocular drug delivery.
@nl
P2093
P2860
P1433
P1476
Solid lipid nanoparticles for ocular drug delivery.
@en
P2093
Ali Seyfoddin
Raida Al-Kassas
P2860
P304
P356
10.3109/10717544.2010.483257
P407
P577
2010-09-01T00:00:00Z